日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Perioperative Nivolumab in Resectable Non-Small Cell Lung Cancer: A Subanalysis of Japanese Patients From CheckMate 77T

围手术期纳武利尤单抗治疗可切除非小细胞肺癌：CheckMate 77T研究中日本患者的亚组分析

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.70300
Tanaka, Fumihiro; Watanabe, Yasutaka; Sugawara, Shunichi; Okami, Jiro; Muto, Satoshi; Okada, Morihito; Horio, Yoshitsugu; Tsuboi, Masahiro; Sato, Yuki; Takamochi, Kazuya; Horinouchi, Hidehito; Tambo, Yuichi; Seike, Masahiro; Okishio, Kyoichi; Coronado Erdmann, Cinthya; Sathyanarayana, Padma; Meadows-Shropshire, Stephanie; Ito, Hiroyuki
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Impact of Sequential Ramucirumab Plus Docetaxel After PD-1 Inhibitors on Anti-PD-1 Antibody-Bound T-Cell Dynamics and Clinical Outcomes

PD-1抑制剂治疗后序贯使用雷莫芦单抗联合多西他赛对抗PD-1抗体结合T细胞动力学和临床结果的影响

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.70336
Matsumoto, Kinnosuke; Naito, Yujiro; Shiroyama, Takayuki; Tamiya, Motohiro; Nishino, Kazumi; Tamiya, Akihiro; Okishio, Kyoichi; Kinehara, Yuhei; Kuge, Tomoki; Mori, Masahide; Satoh, Shingo; Suzuki, Hidekazu; Tetsumoto, Satoshi; Niki, Toshie; Suga, Yasuhiko; Osa, Akio; Minami, Toshiyuki; Koyama, Shohei; Takeda, Yoshito; Takakura, Nobuyuki; Kumanogoh, Atsushi
T细胞
T细胞
细胞生物学
PD-1
免疫/内分泌
发表日期：2026
文献求助 收藏

Impact of early versus delayed surgery on 30-day outcomes in traumatic cervical spinal cord injury: a single-center propensity score-matched cohort study

早期手术与延迟手术对创伤性颈椎脊髓损伤患者30天预后的影响：一项单中心倾向评分匹配队列研究

期刊:European Journal of Medical Research
影响因子:3.4
doi:10.1186/s40001-025-03819-2
Tone, Takuto; Murata, Shizumasa; Hayashi, Taiki; Ueda, Kentaro; Yonemitsu, Takafumi; Nakashima, Tsuyoshi; Shinohara, Natsuyo; Shibata, Naoaki; Okishio, Yuko; Kunitatsu, Kosei; Shima, Nozomu; Shibata, Mami; Kido, Yusuke; Inada, Yukari; Yoshimura, Tomohiro; Yamada, Hiroshi; Inoue, Shigeaki
脊髓损伤
神经科学
发表日期：2026
文献求助 收藏

Noncovalent Synthesis of Amphiphilic Block Copolymers Through Host-Guest Interactions

通过主客体相互作用非共价合成两亲性嵌段共聚物

期刊:Chemistry-An Asian Journal
影响因子:3.3
doi:10.1002/asia.70691
Hirao, Takehiro; Okishio, Yuki; Ema, Ayako; Yoshida, Masaya; Kihara, Shin-Ichi; Haino, Takeharu
发表日期：2026
文献求助 收藏

Durvalumab Post Concurrent Chemoradiotherapy in Japanese Patients With Limited-Stage Small-Cell Lung Cancer in the Phase 3 ADRIATIC Trial

在 ADRIATIC 3 期试验中，度伐利尤单抗用于治疗日本局限期小细胞肺癌患者的同步放化疗后治疗

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.70188
Zenke, Yoshitaka; Shiraishi, Yoshimasa; Goto, Yasushi; Azuma, Koichi; Okishio, Kyoichi; Ogino, Hirokazu; Horio, Yoshitsugu; Oizumi, Satoshi; Hayama, Manabu; Nii, Masahiro; Harada, Masaya; Mann, Helen; Olivo, Yuka S; Jiang, Haiyi; Senan, Suresh
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Efficacy and Safety of Nivolumab Monotherapy in Patients with High PD-1-Positive CD8/Treg Ratio in Advanced NSCLC and Gastric Cancer: A Phase II, Multicenter Study

纳武利尤单抗单药治疗PD-1阳性CD8/Treg比值高的晚期非小细胞肺癌和胃癌患者的疗效和安全性：一项II期多中心研究

期刊:Cancer Research Communications
影响因子:3.3
doi:10.1158/2767-9764.CRC-25-0169
Shitara, Kohei; Tamiya, Motohiro; Okishio, Kyoichi; Hosaka, Hisashi; Shinozaki, Katsunori; Seki, Nobuhiko; Hara, Hiroki; Narita, Yukiya; Shiraishi, Takeshi; Tamura, Yosuke; Tsuji, Akihito; Tsuji, Kunihiro; Watanabe, Naohiro; Tanaka, Hiroshi; Yamaguchi, Toshifumi; Yamaguchi, Kensei; Izumi, Hiroki; Ushida, Yasunori; Suna, Hideaki
胃癌
肺癌
肿瘤
T细胞
肿瘤免疫
CD8
Treg
细胞生物学
PD-1
发表日期：2025
文献求助 收藏

Preoperative Maximum Standardized Uptake Value Emphasized in Explainable Machine Learning Model for Predicting the Risk of Recurrence in Resected Non-Small Cell Lung Cancer

术前最大标准化摄取值在可解释机器学习模型中被强调，用于预测切除的非小细胞肺癌的复发风险

期刊:JCO Clinical Cancer Informatics
影响因子:2.8
doi:10.1200/CCI-24-00194
Iguchi, Takafumi; Kojima, Kensuke; Hayashi, Daiki; Tokunaga, Toshiteru; Okishio, Kyoichi; Yoon, Hyungeun
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Case of a rare EGFR mutation L747P identified using the lung cancer compact Panel™ leading to successful Afatinib treatment

一例罕见的EGFR突变L747P病例，通过肺癌紧凑型基因检测组™（Lung cancer compact Panel™）确诊，并成功接受了阿法替尼治疗。

期刊:Respiratory Medicine Case Reports
影响因子:0.7
doi:10.1016/j.rmcr.2025.102255
Sumitani, Hitoshi; Tamiya, Akihiro; Iwahashi, Yuki; Sekinada, Daisuke; Tsukaguchi, Akihiro; Tanaka, Yuya; Iguchi, Takafumi; Inagaki, Yuji; Taniguchi, Yoshihiko; Kagawa, Tomoko; Matsuda, Yoshinobu; Okishio, Kyoichi
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
发表日期：2025
文献求助 收藏

First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon EGFR Mutations: The UNICORN Phase 2 Nonrandomized Clinical Trial

奥希替尼一线治疗既往未接受治疗的非小细胞肺癌伴罕见EGFR突变患者：UNICORN II期非随机临床试验

期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2023.5013
Okuma, Yusuke; Kubota, Kaoru; Shimokawa, Mototsugu; Hashimoto, Kana; Kawashima, Yosuke; Sakamoto, Tomohiro; Wakui, Hiroshi; Murakami, Shuji; Okishio, Kyoichi; Hayashihara, Kenji; Ohe, Yuichiro
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2024
文献求助 收藏

NOTCH1 and CREBBP co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC: translational research of phase III IMPACT study

NOTCH1 和 CREBBP 共突变对完全切除的 EGFR 突变 NSCLC 辅助治疗的益处产生负面影响：III 期 IMPACT 研究的转化研究

期刊:Molecular Oncology
影响因子:5
doi:10.1002/1878-0261.13542
Satoshi Ikeda, Masahiro Tsuboi, Kazuko Sakai, Toshihiro Misumi, Hiroaki Akamatsu, Hiroyasu Shoda, Noriaki Sakakura, Atsushi Nakamura, Yasuhisa Ohde, Hidetoshi Hayashi, Kyoichi Okishio, Morihito Okada, Ichiro Yoshino, Jiro Okami, Kazuhisa Takahashi, Norihiko Ikeda, Masayuki Tanahashi, Yuichi Tambo, H
信号转导
Notch
发表日期：2024
文献求助 收藏